SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-285792
Filing Date
2022-11-15
Accepted
2022-11-15 16:30:59
Documents
17
Period of Report
2022-11-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d420848d8k.htm   iXBRL 8-K 45746
2 EX-4.1 d420848dex41.htm EX-4.1 60138
3 EX-4.2 d420848dex42.htm EX-4.2 106030
4 EX-10.1 d420848dex101.htm EX-10.1 202401
5 EX-10.2 d420848dex102.htm EX-10.2 249661
6 EX-99.1 d420848dex991.htm EX-99.1 11682
  Complete submission text file 0001193125-22-285792.txt   937494

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA cue-20221114.xsd EX-101.SCH 2870
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cue-20221114_lab.xml EX-101.LAB 17980
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cue-20221114_pre.xml EX-101.PRE 11269
11 EXTRACTED XBRL INSTANCE DOCUMENT d420848d8k_htm.xml XML 3382
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38327 | Film No.: 221391585
SIC: 2834 Pharmaceutical Preparations